知名学者引用


        除了所发表论文的被引用频次、期刊质量能够彰显学者的学术影响力以外,被知名学者引用也是一项学术评价的重要指标。
        当前全球学者库认定的知名学者包括:诺贝尔奖、菲尔兹奖、图灵奖等奖项获得者,多个国家的院士,全球学者库“2023全球学者学术影响力排行版”入榜的前10万学者等。

Shi, Yaqin 南京大学被知名学者引用:195人次(黄金会员以上可以申请导出本人论文被全部知名学者引用的数据)

1. Davidson, Nancy E. 美国 Fred Hutchinson Cancer Center 2011美国医学院院士 Epigenetic modulation of antitumor immunity and immunotherapy response in breast cancer: biological ..

2. John D,Carpten 美国 University of Southern California 2023美国医学院院士 Analysis of the genomic landscapes of Barbadian and Nigerian women with triple negative breast cance..

3. Coussens, Lisa M. 美国 Knight Cancer Institute 2023美国科学院院士 Multiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination ..

4. Gray, Joe W. 美国 Oregon Health & Science University 2011美国医学院院士 Multiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination ..

5. Gupta, Sanjay 美国 Case Western Reserve University 2019美国医学院院士 Long non-coding RNA regulating androgen receptor signaling in breast and prostate cancer

6. Gutkind, J. Silvio 美国 University of California, San Diego 2019美国医学院院士 Beyond Synthetic Lethality: Charting the Landscape of Pairwise Gene Expression States Associated wit..

7. Trey,Ideker 美国 University of California San Diego A deep learning model of tumor cell architecture elucidates response and resistance to CDK4/6 inhibi..

8. Matteo,Lambertini 意大利 University of Genoa CDK4/6 inhibition in hormone receptor-positive/HER2-negative breast cancer: Biological and clinical ..

9. Mario,Scartozzi 意大利 University of Cagliari CDK4/6 inhibition in hormone receptor-positive/HER2-negative breast cancer: Biological and clinical ..

10. Lin, Jiayuh 美国 University of Maryland CDK4/6 inhibitors in lung cancer: current practice and future directions

11. Philippe L,Bedard 加拿大 University of Toronto Seize the engine: Emerging cell cycle targets in breast cancer

12. Sankha.K,Bhattacharya 印度 Banaras Hindu University Polymeric nanoparticles approach and identification and characterization of novel biomarkers for col..

13. 谢小明 中国 中山大学 Dissection of FOXO1-Induced LYPLAL1-DT Impeding Triple-Negative Breast Cancer Progression via Mediat..

14. Gary K,Schwartz 美国 Columbia University Sequential activation of E2F via Rb degradation and c-Myc drives resistance to CDK4/6 inhibitors in ..

15. Sarat,Chandarlapaty 美国 Memorial Sloan-Kettering Cancer Center Sequential activation of E2F via Rb degradation and c-Myc drives resistance to CDK4/6 inhibitors in ..

16. Claudio,Sette 意大利 University of Cattolica Sacro Cuore Recent Advances in Drug Discovery for Triple-Negative Breast Cancer Treatment

17. Romano,Silvestri 意大利 Sapienza University of Rome Recent Advances in Drug Discovery for Triple-Negative Breast Cancer Treatment

18. Mohammad,Taheri 伊朗 SHAHID BEHESHTI UNIVERSITY MEDICAL SCIENCES Role of long non-coding RNAs and TGF-? signaling in the regulation of breast cancer pathogenesis and..

19. Sooryanarayana,Varambally 美国 University of ALABAMA Whole-Exome Sequencing Reveals High Mutational Concordance between Primary and Matched Recurrent Tri..

20. 吴孔明 中国 华中科技大学 教授,主任医师 Recent advances in targeted strategies for triple-negative breast cancer

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3